Loading...
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
BACKGROUND: Despite the known risk of diabetes-induced cardiac fibrosis, less is known about whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Peroxisome proliferator-activated receptor δ (PPARδ), a versatile regulator of metabolic homeostasis, may be a po...
Saved in:
| Published in: | Cardiovasc Diabetol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4983091/ https://ncbi.nlm.nih.gov/pubmed/27519769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0430-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|